Obesity and heart failure as a mediator of the cerebrorenal interaction

Contributions to Nephrology

Volumn 179, Issue , 2013, Pages 15-23

  Jindal, Ankur ^a   Whaley Connell, Adam ^a   Sowers, James R ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID;

ADIPOCYTE; ANIMAL; ARTICLE; BIOLOGICAL MODEL; BRAIN; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; COMORBIDITY; DISEASE COURSE; DISEASE MODEL; DISEASE PREDISPOSITION; EPIDEMIOLOGY; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; KIDNEY; METABOLISM; OBESITY; OVERNUTRITION; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR;

ADIPOCYTES; ANIMALS; BRAIN; CAUSALITY; COHORT STUDIES; COMORBIDITY; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; FATTY ACIDS, NONESTERIFIED; HEART FAILURE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INFLAMMATION; INSULIN RESISTANCE; KIDNEY; MODELS, BIOLOGICAL; MYOCARDIUM; OBESITY; OVERNUTRITION; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; STROKE;

EID: 84926081400     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000346718     Document Type: Article

References (37)

1. Flegal KM, Carroll MD, Kit BK, Ogden CL: Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307: 491-497
2. Appelros P, Nydevik I, Seiger A, Terent A: Predictors of severe stroke: influence of preexisting dementia and cardiac disorders. Stroke 2002; 33: 2357-2362
3. Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyren O: Obesity and risk for chronic renal failure. J Am Soc Nephrol 2006; 17: 1695-1702
4. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS: Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144: 21-28
5. Sowers JR, Whaley-Connell A, Hayden MR: The role of overweight and obesity in the cardiorenal syndrome. Cardiorenal Med 2011; 1: 5-12
6. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, Hennekens CH, Speizer FE: Body weight and mortality among women. N Engl J Med 1995; 333: 677-685
7. Wilson PW, DAgostino RB, Sullivan L, Parise H, Kannel WB: Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002; 162: 1867-1872
8. Bombelli M, Facchetti R, Fodri D, Brambilla G, Sega R, Grassi G, Mancia G: Impact of body mass index and waist circumference on the cardiovascular risk and all-cause death in a general population: data from the PAMELA study. Nutr Metab Cardiovasc Dis 2012, Epub ahead of print
9. Bogers RP, Bemelmans WJ, Hoogenveen RT, Boshuizen HC, Woodward M, Knekt P, van Dam RM, Hu FB, Visscher TL, Menotti A, Thorpe RJ Jr, Jamrozik K, Calling S, Strand BH, Shipley MJ, for the BMI-CHD Collaboration Investigators: Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300,000 persons. Arch Intern Med 2007; 167: 1720-1728
10. Alpert MA: Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci 2001; 321: 225-236
11. Turkbey EB, McClelland RL, Kronmal RA, Burke GL, Bild DE, Tracy RP, Arai AE, Lima JA, Bluemke DA: The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA). JACC Cardiovasc Imaging 2010; 3: 266-274
12. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS: Obesity and the risk of heart failure. N Engl J Med 2002; 347: 305-313
13. Cil H, Bulur S, Turker Y, Kaya A, Alemdar R, Karabacak A, Aslantas Y, Ekinozu I, Albayrak S, Ozhan H, MELEN Investigators: Impact of body mass index on left ventricular diastolic dysfunction. Echocardiography 2012; 29: 647-651
14. Alpert MA, Chan EJ: Left ventricular morphology and diastolic function in severe obesity: current views. Rev Esp Cardiol (Engl) 2012; 65: 1-3
15. Lionetti L, Mollica MP, Lombardi A, Cavaliere G, Gifuni G, Barletta A: From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation. Nutr Metab Cardiovasc Dis 2009; 19: 146-152
16. van de Weijer T, Schrauwen-Hinderling VB, Schrauwen P: Lipotoxicity in type 2 diabetic cardiomyopathy. Cardiovasc Res 2011; 92: 10-18
17. Anderson EJ, Kypson AP, Rodriguez E, Anderson CA, Lehr EJ, Neufer PD: Substratespecific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart. J Am Coll Cardiol 2009; 54: 1891-1898
18. Duncan JG: Mitochondrial dysfunction in diabetic cardiomyopathy. Biochim Biophys Acta 2011; 1813: 1351-1359
19. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH: Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 2000; 97: 1784-1789
20. Peterson LR, Herrero P, Schechtman KB, Racette SB, Waggoner AD, Kisrieva-Ware Z, Dence C, Klein S, Marsala J, Meyer T, Gropler RJ: Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 2004; 109: 2191-2196
21. Witt BJ, Gami AS, Ballman KV, Brown RD Jr, Meverden RA, Jacobsen SJ, Roger VL: The incidence of ischemic stroke in chronic heart failure: a meta-analysis. J Card Fail 2007; 13: 489-496
22. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, ODonnell C, Kittner S, Lloyd-Jones D, Goff DC Jr, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel- Smoller S, Wilson M, Wolf P: Heart disease and stroke statistics: 2006 update - a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113:e85-e151
23. Wolf PA, DAgostino RB, Kannel WB, Bonita R, Belanger AJ: Cigarette smoking as a risk factor for stroke: the Framingham study. JAMA 1988; 259: 1025-1029
24. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991; 22: 983-988
25. Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, Wolf PA: The lifetime risk of stroke: estimates from the Framingham Study. Stroke 2006; 37: 345-350
26. Strazzullo P, DElia L, Cairella G, Garbagnati F, Cappuccio FP, Scalfi L: Excess body weight and incidence of stroke: meta-analysis of prospective studies with 2 million participants. Stroke 2010; 41:e418-e426
27. Yatsuya H, Toyoshima H, Yamagishi K, Tamakoshi K, Taguri M, Harada A, Ohashi Y, Kita Y, Naito Y, Yamada M, Tanabe N, Iso H, Ueshima H, Japan Arteriosclerosis Longitudinal Study (JALS) Group: Body mass index and risk of stroke and myocardial infarction in a relatively lean population: meta-analysis of 16 Japanese cohorts using individual data. Circ Cardiovasc Qual Outcomes 2010; 3: 498-505
28. Wilson PW, DAgostino RB, Sullivan L, Parise H, Kannel WB: Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002; 162: 1867-1872
29. Kannel WB, Cupples LA, Ramaswami R, Stokes J, Kreger BE, Higgins M: Regional obesity and risk of cardiovascular disease: the Framingham Study. J Clin Epidemiol 1991; 44: 183-190
30. Friedemann C, Heneghan C, Mahtani K, Thompson M, Perera R, Ward AM: Cardiovascular disease risk in healthy children and its association with body mass index: systematic review and meta-analysis. BMJ 2012; 345:e4759
31. Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyren O: Obesity and risk for chronic renal failure. J Am Soc Nephrol 2006; 17: 1695-1702
32. Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, Narita M, Koyama A: Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int 2007; 71: 159-166
33. Sowers JR, Whaley-Connell A, Hayden MR: The role of overweight and obesity in the cardiorenal syndrome. Cardiorenal Med 2011; 1: 5-12
34. Dhingra R, Gaziano JM, Djousse L: Chronic kidney disease and the risk of heart failure in men. Circ Heart Fail 2011; 4: 138-144
35. Koren-Morag N, Goldbourt U, Tanne D: Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease. Neurology 2006; 67: 224-228
36. Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS, McClellan W: Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC study. Kidney Int 2003; 64: 610-615
37. Nakayama M, Metoki H, Terawaki H, Ohkubo T, Kikuya M, Sato T, Nakayama K, Asayama K, Inoue R, Hashimoto J, Totsune K, Hoshi H, Ito S, Imai Y: Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population: the Ohasama study. Nephrol Dial Transplant 2007; 22: 1910-1915